Clinical and Experimental Dermatology 2006-07-01

Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.

H Ujiie, T Shimizu, K Natsuga, K Arita, K Tomizawa, H Shimizu

Index: Clin. Exp. Dermatol. 31(4) , 588-9, (2006)

Full Text: HTML

Abstract

Structure	Name/CAS No.	Molecular Formula	Articles
	Oxatomide CAS:60607-34-3	C₂₇H₃₀N₄O

Treatment of allergic rhinitis in infants and children: effi...
2009-01-01
[Drugs 69(18) , 2541-76, (2009)]

Differential thermodynamic driving force of first- and secon...
2014-09-15
[Biochem. Pharmacol. 91(2) , 231-41, (2014)]

Molecular complexes of ketaconazole and oxatomide with p-chl...
2011-09-01
[Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 79(5) , 1137-44, (2011)]

High-performance liquid chromatographic determination of oxa...
2002-01-01
[Arzneimittelforschung 52(10) , 754-63, (2002)]

Effect of oxatomide, an antiallergic agent, on QT interval i...
2001-01-01
[Arzneimittelforschung 51(12) , 971-6, (2001)]

Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.

Abstract

Related Compounds